The
obesity market in North America will be worth a huge US$139.5 billion
by 2017, according to a report by MarketsandMarkets, a global market
research and consulting company based in the US. The obesity market in
North America was estimated to be worth US$104 billion in 2012-13.
According to industry experts, US has over 70 Million obese individuals, there are about 15 Million who are super obese that are ready for surgical treatment because diet and exercise has not worked for them and suffer from major co-morbidities like diabetes and heart disease. Assuming a medical device is sold for $8000, it translates into a $120 Billion market just today. This number is increasing by 10% year after year.
If these numbers are not taken care off, the health care crisis may grow. American Medical Association has declared obesity as a disease and CDC and FDA are working on enabling more technologies available to the needy.
If we include the ‘North America Weight Loss/Obesity Management Market - [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, gastric surgery -it measures up to $580 Billion market Forecasts to 2017’, analyses and studies the major market drivers, restraints, and opportunities in US and Canada.
The report states that the market continues to be driven by increasing obesity rates, as well as increasing levels of awareness amongst calorie-conscious consumers in North America, which have opened new avenues for the weight management industry.
The report also claims that bariatric surgery remains popular,
although patients are opting for less-invasive and reversible methods of
weight loss surgery following several studies questioning the long-term
effectiveness of surgery as well as some adverse events related to removal of stomach or parts of the stomach and intestines. In this sector the Gastric bands are reemerging and newer players like Onciomed's GVS system is the next generation of minimally invasive and yet reversible technology.
The research categorises the North America weight loss/obesity management market into weight loss diets, fitness and surgical equipment, and services. These markets are broken down into segments and sub-segments, providing analysis for forecast up to 2017. The North America weight loss diets (food, beverages, & supplements), fitness and surgical equipment, and services, with forecast to 2017.
The report states that the key companies in the weight loss diet market are:
The surgical equipment market include devices used either for weight loss or for surgical removal of the gut or of extra fat from the body. The weight loss surgical equipment market exhibits very high growth potential and is estimated to grow at a double-digit rate from 2012 to 2017. This market is estimated to be around $260B , the diet and exercise market to be close to $120 B additionally the low cal food industry continues to grow to $300B.
The surgical and plastic surgery market numbers are high.This is attributed to the increasing number of bariatric surgeries,
technological advancements resulting in less pain and early recovery,
and acceptance of surgical procedures by a large population worldwide.
Weight loss diet was the largest segment in the market. Its growth is primarily triggered by new product launches, increasing consumer awareness of diet food and beverages, increasing number of diabetic patients, and aggressive marketing strategies adopted by market players. Low calorie beverages (carbonated and non-carbonated), and slimmer waters/natural mineral salt drinks showcase vast opportunities for key players in the market. The herbal/green market is growing at a very fast pace in Asian countries, especially in China.
India has over 12 Million super obese individuals in urban India that are waiting for surgical intervention, the country has over 70 Million obese and 62 million diabetic patients. This trend is attributed to sudden change in lifestyle and diet. The patients are affluent and can pay out of pocket for surgical procedures which cost approximately $15,000 to $20,000 depending on the use of medical devices. US made medical devices are popular in Asia for their quality and effectiveness.
China has a similar story with a growing adolescent population that is obese. China leads the childhood obesity in 2013 with a disturbing 120Million obese children and adolescent. Chinese parents blame it on the increase influence of western culture and fast food.
China will be the leading user of minimally invasive surgical devices. Chinese doctors prefer US made medical product for \reliable outcomes. China laparoscopic market is large because of over 30 thousand laparoscopic tubal ligations are done every year.
Mexico, Brazil and Europe are seeing obesity in epidemic proportions.
Australia has already declared obesity as a health threat and has taken several measures to curb obesity.
The obesity index in Australia has increased by over 30% since 2012. Mexico's obesity index has gone up by 300% in the last decade. Cost of gastric surgery is less but still remains to be out of pocket expense.
American Medical Association has announced obesity as a disease, this has changed the market considerably, there have been more interest and investment in innovations treating obesity.
By 2017, large companies will be acquiring young companies at a premium for technologies that can be minimally invasive and can enable surgeons to get better results. Some of the leaders in the new breed of technologies include GiDynamics, Onciomed, Reshape, Baranova,
Enteromedics & Obalon.
According to industry experts, US has over 70 Million obese individuals, there are about 15 Million who are super obese that are ready for surgical treatment because diet and exercise has not worked for them and suffer from major co-morbidities like diabetes and heart disease. Assuming a medical device is sold for $8000, it translates into a $120 Billion market just today. This number is increasing by 10% year after year.If these numbers are not taken care off, the health care crisis may grow. American Medical Association has declared obesity as a disease and CDC and FDA are working on enabling more technologies available to the needy.
If we include the ‘North America Weight Loss/Obesity Management Market - [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, gastric surgery -it measures up to $580 Billion market Forecasts to 2017’, analyses and studies the major market drivers, restraints, and opportunities in US and Canada.
The report states that the market continues to be driven by increasing obesity rates, as well as increasing levels of awareness amongst calorie-conscious consumers in North America, which have opened new avenues for the weight management industry.
The research categorises the North America weight loss/obesity management market into weight loss diets, fitness and surgical equipment, and services. These markets are broken down into segments and sub-segments, providing analysis for forecast up to 2017. The North America weight loss diets (food, beverages, & supplements), fitness and surgical equipment, and services, with forecast to 2017.
The report states that the key companies in the weight loss diet market are:
- Atkins Nutritionals, Inc. (US)
- Weight Watchers International, Inc. (US)
- NutriSystem, Inc. (US)
- Herbalife International, Inc. (US)
- The Coca Cola Company (US); and
- PepsiCo, Inc. (US)
- Equinox, Inc. (US)
- Gold's Gym International, Inc. (US)
- Weight Watchers International, Inc. (US); and
- eDiets.com (US)
- Ethicon Endo-surgery, Inc. (US)
- Cynosure, Inc. (US); and
- Apollo Endo (US)
- J&J (US)
- Onciomed, Inc (US)
- Reshape Medical (US)
- Obalon Inc (US)
- Enteromedics (US)
- GiDynamics (US).
- Covidien acquired by Medtronic.
The surgical equipment market include devices used either for weight loss or for surgical removal of the gut or of extra fat from the body. The weight loss surgical equipment market exhibits very high growth potential and is estimated to grow at a double-digit rate from 2012 to 2017. This market is estimated to be around $260B , the diet and exercise market to be close to $120 B additionally the low cal food industry continues to grow to $300B.
Weight loss diet was the largest segment in the market. Its growth is primarily triggered by new product launches, increasing consumer awareness of diet food and beverages, increasing number of diabetic patients, and aggressive marketing strategies adopted by market players. Low calorie beverages (carbonated and non-carbonated), and slimmer waters/natural mineral salt drinks showcase vast opportunities for key players in the market. The herbal/green market is growing at a very fast pace in Asian countries, especially in China.
India has over 12 Million super obese individuals in urban India that are waiting for surgical intervention, the country has over 70 Million obese and 62 million diabetic patients. This trend is attributed to sudden change in lifestyle and diet. The patients are affluent and can pay out of pocket for surgical procedures which cost approximately $15,000 to $20,000 depending on the use of medical devices. US made medical devices are popular in Asia for their quality and effectiveness.
China will be the leading user of minimally invasive surgical devices. Chinese doctors prefer US made medical product for \reliable outcomes. China laparoscopic market is large because of over 30 thousand laparoscopic tubal ligations are done every year.
Mexico, Brazil and Europe are seeing obesity in epidemic proportions.
Australia has already declared obesity as a health threat and has taken several measures to curb obesity.
The obesity index in Australia has increased by over 30% since 2012. Mexico's obesity index has gone up by 300% in the last decade. Cost of gastric surgery is less but still remains to be out of pocket expense.American Medical Association has announced obesity as a disease, this has changed the market considerably, there have been more interest and investment in innovations treating obesity.
By 2017, large companies will be acquiring young companies at a premium for technologies that can be minimally invasive and can enable surgeons to get better results. Some of the leaders in the new breed of technologies include GiDynamics, Onciomed, Reshape, Baranova,
Enteromedics & Obalon.
